EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Convergent Hybrid Ablation and Concomitant Left Atrial Appendage Exclusion for Stroke Prevention and Rhythm Control in Persistent Atrial Fibrillation

Yonas R Toma iD, Sune Damgaard iD, Christian L Carranza iD

Journal of Clinical Medicine · 30.04.2026 · 15 (9) · 3440

DOI: 10.3390/jcm15093440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.04.2026. Verfasst von Yonas R Toma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Persistent and long-standing persistent atrial fibrillation (AF) presents a therapeutic clinical challenge balancing complex rhythm management with a heightened stroke risk. The left atrial appendage (LAA) is the primary source of thromboembolisms in these patients. This study evaluated the safety and efficacy of combining LAA exclusion with Convergent Hybrid Ablation for stroke prevention and rhythm control in a refractory patient cohort.

Methods

A single-center observational cohort study was conducted including 28 patients with symptomatic persistent or long-standing persistent AF. The cohort was highly refractory, with 82.1% having failed at least one endocardial catheter ablation. The hybrid procedure consisted of sub-xiphoid epicardial ablation, thoracoscopic LAA exclusion (AtriClip), and endocardial catheter ablation. Safety and efficacy were assessed at 3 months and 12 months.

Results

LAA exclusion was successfully performed in 96.4% of patients. The peri-operative safety profile was acceptable, with zero procedure-related strokes or deaths. At the 12-month follow-up, the rate of stroke or any other major adverse events was at 0.0%. Freedom from AF was 75.0%, shown by a 12-lead electrocardiography (ECG). Freedom from any atrial arrhythmia off anti-arrhythmic drugs (AADs) was achieved in 50.0% of patients. A total of 32.1% of the cohort required catheter ablation within 12 months to maintain sinus rhythm as part of the hybrid treatment.

Conclusions

Concomitant LAA exclusion during Convergent Hybrid Ablation is a safe procedure with a high clinical success rate in maintaining sinus rhythm in a highly complex AF patient group. While no thromboembolic events were observed at 12 months, larger studies with longer follow-up are needed to confirm the potential for long-term stroke risk reduction. The findings suggest that for many patients, the hybrid procedure should be viewed as part of a multi-step strategy often requiring endocardial “touch-up” ablation.

Schlagwörter

Stichwörter der Autor:innen

atrial fibrillationconvergent procedurehybrid ablationleft atrial appendage exclusionrhythm controlstroke prevention

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark.

ORCID-Profile: Yonas R Toma, Sune Damgaard, Christian L Carranza

Zitieren

APA

Toma, Y. R., Damgaard, S., & Carranza, C. L. (2026). Convergent Hybrid Ablation and Concomitant Left Atrial Appendage Exclusion for Stroke Prevention and Rhythm Control in Persistent Atrial Fibrillation. Journal of Clinical Medicine, 15(9), 3440. https://doi.org/10.3390/jcm15093440

Vancouver

Toma YR, Damgaard S, Carranza CL. Convergent Hybrid Ablation and Concomitant Left Atrial Appendage Exclusion for Stroke Prevention and Rhythm Control in Persistent Atrial Fibrillation. Journal of Clinical Medicine. 2026;15(9):3440. doi:10.3390/jcm15093440

BibTeX
@article{Toma2026,
  author = {Toma, Yonas R and Damgaard, Sune and Carranza, Christian L},
  title = {Convergent Hybrid Ablation and Concomitant Left Atrial Appendage Exclusion for Stroke Prevention and Rhythm Control in Persistent Atrial Fibrillation},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {3440},
  doi = {10.3390/jcm15093440}
}
Kostenlos starten →